Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Zotide PEN Device
Manufacturer/Marketed By : CIPLA LTD
$20.93 $19.25
The Zotide Pen Device is a reusable injection pen developed by Cipla Ltd. It is designed to administer teriparatide, a synthetic form of parathyroid hormone (PTH), used in the treatment...
Active Pharmaceutical Ingredient
Zotide PEN Device
$20.93
$19.25
The Zotide Pen Device is a reusable injection pen developed by Cipla Ltd. It is designed to administer teriparatide, a synthetic form of parathyroid hormone (PTH), used in the treatment of osteoporosis. Osteoporosis is a condition characterised by weakened bones, which increases the risk of fractures. This device facilitates the subcutaneous injection of teriparatide, promoting bone formation and strength. It's important to note that the Zotide Pen Device does not contain any medication itself. It must be used in conjunction with Zotide cartridges, which contain teriparatide, and Zotide Pen Needles. Before using this device, consult with a healthcare professional to ensure proper usage and to discuss any potential risks or contraindications.
Active Pharmaceutical Ingredient
Uses
• Osteoporosis in postmenopausal women at high risk for fractures.
• Primary or hypogonadal osteoporosis in men at high risk for fractures.
• Glucocorticoid-induced osteoporosis in men and women at high risk for fractures.
Benefits
Teriparatide, administered using the Zotide Pen Device, mimics the activity of the natural parathyroid hormone in the body. It stimulates the activity of osteoblasts, the cells responsible for bone formation. This leads to increased bone mineral density and strength, reducing the risk of fractures associated with osteoporosis. Regular administration as prescribed can help in the effective management of osteoporosis.
Side Effects
Common Side Effects:
Most Common Side Effects
• Hypercalcemia (elevated calcium levels)
• Allergic reactions (rash, itching, swelling)
• Osteosarcoma (a rare type of bone cancer)
Common Side Effects
• Injection site reactions (pain, redness, swelling)
• Nausea
• Leg cramps
• Dizziness
How To Use
To use the Zotide Pen Device:
Safety Advice
• Breast Feeding: Teriparatide administration via the Zotide Pen Device is unsafe while breastfeeding. Seek medical advice prior to use.
• Alcohol: Consumption of alcohol may interfere with bone health and the effectiveness of teriparatide. Consult a doctor regarding alcohol use.
• Liver: Limited data is available on the use of teriparatide in patients with liver disease. Consult doctor before initiating therapy.
• Lungs: There is no known direct impact on lung function; however, if you have pre-existing lung conditions, consult your healthcare provider.
• Driving: If you experience dizziness or other side effects after injection, avoid driving or operating heavy machinery.
• Pregnancy: The use of the Zotide Pen Device for administering teriparatide is unsafe during pregnancy. Consult your doctor before use.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.